Cellectis S.A. (EPA:ALCLS)
France · Delayed Price · Currency is EUR 4.035
+0.305 (8.18%)
Dec 22, 2025, 4:39 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €269.77 million as of December 22, 2025. Its market cap has increased by 103.54% in one year.
Market Cap
269.77M
Enterprise Value
300.97M
Revenue
70.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.04
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 269.77M, an increase of 168.18%. That is a compound annual growth rate of 5.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 269.77M | 130.01% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | 1.04B | 55.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 126.72B |
| Sanofi | 100.24B |
| Sartorius Stedim Biotech | 19.88B |
| bioMérieux | 12.86B |
| Eurofins Scientific SE | 10.93B |
| Ipsen | 9.88B |
| ABIVAX Société Anonyme | 7.78B |
| Virbac | 2.93B |